Printer Friendly

Anti-Doping Enforcement for International Winter Sports Competition Aided by AB SCIEX Testing Solution.

Officials Increase Efforts to Enforce Zero-Tolerance Policy

VANCOUVER, British Columbia -- While millions of viewers around the world are watching breathtaking ski jumps, razor-sharp skating moves and other awe-inspiring athletic feats in Vancouver over the next few weeks, the official doping control laboratory of the 2010 Winter Games will be casting an equally intent eye on the athletes who are competing. The INRS-Institut Armand-Frappier, a component of Canada's Institut national de la recherche scientifique, is implementing the most stringent anti-doping testing in history through the creation of an $8.9-million testing facility. Testing for stimulants, masking agents, glucocorticosteroids and insulin will be run on a mass spectrometry solution provided by AB SCIEX, a global leader in life science analytical technologies.

Officials are enforcing a zero-tolerance policy for performance-enhancing drugs. A critical part of the enforcement is the use of more sensitive technology to ensure the most accurate results that identify cheating. The INRS laboratory, which is Canada's only World Anti-Doping Agency-accredited laboratory, selected AB SCIEX technology, which is among the most advanced in the world for identifying the variety of prohibited substances or their markers.


* The AB SCIEX technology solution deployed by INRS is a mass spectrometry solution based on liquid chromatography/tandem mass spectrometry (LC/MS/MS), which enables comprehensive detection and identification of substances with high specificity and sensitivity.

* The specific solution is comprised of four 4000 QTRAP([R]) Systems. The QTRAP system is a mass spectrometer that provides the unique ability to screen, quantitate and confirm molecules in a single analysis. The software that is used is Analyst Software, which manages the system and performs the data processing.

* The solution utilizes a direct injection method, which is a process by which a scientist directly injects a diluted sample into an instrument, eliminating the need to clean up, concentrate or chemically modify the sample prior to analysis. This simplifies the preparation of the samples submitted to testing, speeds up the process and reduces risks of contamination or loss of compounds.


Christiane Ayotte, Ph.D., director of the doping control laboratory at the 2010 Winter Games

"We have raised the standard for anti-doping testing. By selecting AB SCIEX technology, we are able to consolidate our testing procedures, significantly reduce the preparation steps and increase the sensitivity and specificity of our detection techniques."

Laura Lauman, president of AB SCIEX

"Protecting the integrity of athletic competition continues to be a significant issue for international governing organizations. AB SCIEX technology is assisting in the enforcement of a zero-tolerance, anti-doping policy designed to maintain a level playing field during the Winter Games. This is a great example of how mass spectrometry is increasingly being used to address a variety of scientific challenges beyond the research lab."

Media Resources

"This is AB SCIEX" (Corporate video)

AB SCIEX technology portfolio


AB SCIEX is a global leader in the development of life science analytical technologies that help answer complex scientific challenges. The company provides scientific instrumentation, software and services used to discover new drugs, advance medical science and protect the food supply and the environment. The company has a more than 20-year history of innovation and market leadership as the former Applied Biosystems/MDS Analytical Technologies joint venture. For more information about AB SCIEX, go to Follow AB SCIEX on Twitter @ABSCIEX and on Facebook.

Social Media Tags

AB SCIEX, performance-enhancing drugs, Olympics, 2010 Winter Games, mass spectrometry, QTRAP, life science, analytical technologies, anti-doping

For Research Use Only. The trademarks mentioned herein are the property of AB Sciex Pte. Ltd. or their respective owners.

[c] 2010 AB SCIEX.

Photos/Multimedia Gallery Available:
COPYRIGHT 2010 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Feb 10, 2010
Previous Article:DJO Incorporated Announces Date for Release of Fourth Quarter and Full Year 2009 Results.
Next Article:Hythiam Announces Peer-Reviewed Publication of Randomized, Double-Blind, Placebo-Controlled Study.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters